INTP Stock Overview
Integrated Pharmaceuticals, Inc. develops and produces specialty chemicals and nutraceuticals in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Integrated Pharmaceuticals, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -99.92% |
| 5 Year Change | -99.97% |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| INTP | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | -1.5% | -3.2% |
| 1Y | n/a | 9.7% | 19.3% |
Return vs Industry: Insufficient data to determine how INTP performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how INTP performed against the US Market.
Price Volatility
| INTP volatility | |
|---|---|
| INTP Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.8% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: INTP has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine INTP's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1969 | n/a | n/a | n/a |
Integrated Pharmaceuticals, Inc. develops and produces specialty chemicals and nutraceuticals in the United States. It offers compounds and nutraceuticals that have proven therapeutic or nutritional value in humans, plants, and animals. The company also develops technologies for the production of clinically active pharmaceutical compounds, including active small molecules and recombinant DNA technology derived products.
Integrated Pharmaceuticals, Inc. Fundamentals Summary
| INTP fundamental statistics | |
|---|---|
| Market cap | US$47.00 |
| Earnings (TTM) | -US$1.70m |
| Revenue (TTM) | US$27.00k |
0.0x
P/S Ratio0.0x
P/E RatioIs INTP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| INTP income statement (TTM) | |
|---|---|
| Revenue | US$27.00k |
| Cost of Revenue | US$4.73k |
| Gross Profit | US$22.28k |
| Other Expenses | US$1.72m |
| Earnings | -US$1.70m |
Last Reported Earnings
Jun 30, 2008
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did INTP perform over the long term?
See historical performance and comparison